James Tai’s broad life sciences and health care experience spans a wide array of outpatient provider services for chronic diseases to venture capital for life sciences companies. He sits on the board of directors for a variety of transformational health care companies that aim to improve health equity and access for underserved communities. 

He is currently the chair of the ADA’s Innovation Committee. James has been instrumental in shaping and accelerating the growth of the ADA Innovation Fund—helping to expand its strategic vision, strengthen its investment pipeline, and position the ADA Innovation Fund as a catalyst for novel diabetes and obesity solutions.